Home india India Equity: Parmax_Pharma (#540359) declares Quarterly Results. EPS = Rs -1.18 for quarter ended Jun 2021

India Equity: Parmax_Pharma (#540359) declares Quarterly Results. EPS = Rs -1.18 for quarter ended Jun 2021

0
India Equity: Parmax_Pharma (#540359) declares Quarterly Results. EPS = Rs -1.18 for quarter ended Jun 2021

Join the India Equity Telegram Group for analysis, updates and results

540359 has declared results for the period ended Jun 2021.

Quarterly Results

[s2If !current_user_can(access_s2member_level1)] Register and Login below to read result analysis [lwa][/s2If] [s2If current_user_can(access_s2member_level1)]

  • Sales for period ended Jun 2021 is Rs 1.73 cr compared to Rs 2.27 cr for period ended Jun 2020, a fall of 23.8%
  • Company reported operating profit of Rs 0.11 cr for period ended Jun 2021, operating profit margin at 6.4 %.
  • Operating profit was negative for the same period last year thus company has improved its margins this year
  • The EPS for Jun 2021 was Rs -1.18 compared to Rs -0.8 for previous quarter ended Mar 2021 and Rs -2.67 for Jun 2020
  • The stock is trading at Rs 47.45 and a market cap of Rs 18 cr

[/s2If]

Trading Chart


Further analysis and Full Company Research with investing scores is available here: 540359

Join BharatEquity Telegram Channel for updated India results, analysis and News
Join Our Twitter